These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
572 related articles for article (PubMed ID: 19030857)
1. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome. Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857 [TBL] [Abstract][Full Text] [Related]
2. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843 [TBL] [Abstract][Full Text] [Related]
3. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study. Rigacci L; Carrai V; Nassi L; Alterini R; Longo G; Bernardi F; Bosi A Cancer; 2005 Mar; 103(5):970-7. PubMed ID: 15666323 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca]. Madani A; Benhmiddoune L; Zafad S; Harif M; Quessar A; Benchekroun S Bull Cancer; 2005 Feb; 92(2):193-8. PubMed ID: 15749649 [TBL] [Abstract][Full Text] [Related]
5. A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas. Kujawski LA; Longo WL; Williams EC; Turman NJ; Brandt N; Mosher DF; Eickhoff JC; Kahl BS Cancer Invest; 2007 Mar; 25(2):87-93. PubMed ID: 17453819 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents]. Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797 [TBL] [Abstract][Full Text] [Related]
8. Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. van Imhoff GW; van der Holt B; MacKenzie MA; Ossenkoppele GJ; Wijermans PW; Kramer MH; van 't Veer MB; Schouten HC; van Marwijk Kooy M; van Oers MH; Raemaekers JM; Sonneveld P; Meulendijks LA; Kluin PM; Kluin-Nelemans HC; Verdonck LF; Leukemia; 2005 Jun; 19(6):945-52. PubMed ID: 15800666 [TBL] [Abstract][Full Text] [Related]
9. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma. Yamanaka R; Morii K; Shinbo Y; Takeuchi S; Tamura T; Hondoh H; Takahashi H; Onda K; Takahashi H; Tanaka R Ann Hematol; 2005 Jul; 84(7):447-55. PubMed ID: 15747120 [TBL] [Abstract][Full Text] [Related]
10. Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol. Acquatella G; Insausti CL; García R; Gómez R; Hernández M; Carneiro M; Santos S; Nouel A Pediatr Blood Cancer; 2004 Oct; 43(5):580-6. PubMed ID: 15382276 [TBL] [Abstract][Full Text] [Related]
11. Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimen. Baer MR; Stein RS; Greer JP; Wolff SN; Hainsworth JD; Flexner JM Cancer Treat Rep; 1986 Jun; 70(6):785-7. PubMed ID: 3488125 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan. Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129 [TBL] [Abstract][Full Text] [Related]
13. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413 [TBL] [Abstract][Full Text] [Related]
14. Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial. Weiss R; Mitrou P; Arasteh K; Schuermann D; Hentrich M; Duehrsen U; Sudeck H; Schmidt-Wolf IG; Anagnostopoulos I; Huhn D Cancer; 2006 Apr; 106(7):1560-8. PubMed ID: 16502436 [TBL] [Abstract][Full Text] [Related]
16. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature. Baeksgaard L; Sørensen JB Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435 [TBL] [Abstract][Full Text] [Related]
17. Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol. Patte C; Sakiroglu C; Ansoborlo S; Baruchel A; Plouvier E; Pacquement H; Babin-Boilletot A; Ann Oncol; 2002 May; 13(5):789-95. PubMed ID: 12075750 [TBL] [Abstract][Full Text] [Related]
18. Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity. Lacasce A; Howard O; Lib S; Fisher D; Weng A; Neuberg D; Shipp M Leuk Lymphoma; 2004 Apr; 45(4):761-7. PubMed ID: 15160953 [TBL] [Abstract][Full Text] [Related]
19. Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea. Choi MK; Jun HJ; Lee SY; Kim KH; Lim DH; Kim K; Ko YH; Kim WS; Kim SJ Ann Hematol; 2009 Nov; 88(11):1099-106. PubMed ID: 19288103 [TBL] [Abstract][Full Text] [Related]
20. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma. De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]